Search results
Found 1358 matches for
A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.
©
Doctur4U
New heart disease calculator could save lives by identifying high-risk patients missed by current tools
General Research
18 April 2024
Collaborative research, led by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.
New trial using skin patches as an ‘early warning system’ to spot lung transplant rejection
General Research
17 April 2024
A new trial, SENTINEL, is set to investigate if skin patches can be used as an early warning system to identify if lung transplants are being rejected, so treatment can begin sooner, reducing the chance of longer lasting organ damage.
Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine
General Innovation Research
16 April 2024
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.
Breakthrough aerosol human infection model gives hope for future tuberculosis vaccine development
General Research
16 April 2024
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs – the way TB enters the body.
Study challenges conventional understanding of household air pollution's impact on fetal growth
General Research
15 April 2024
In a ground-breaking study published today in Lancet Global Health, researchers present findings challenging conventional wisdom regarding the impact of household air pollution on fetal growth. The study, conducted in 3200 households across resource-poor settings in Guatemala, India, Rwanda, and Peru, focused on assessing the effects of reducing personal exposures to household air pollution on fetal growth in a randomized controlled trial.
DPAG Retains Top Spot in QS World University Rankings for Anatomy and Physiology
General
10 April 2024
In the QS World University Rankings for 2024, DPAG has once again secured first position for Anatomy and Physiology. This achievement marks the seventh time in the last eight years that Oxford has claimed the top spot in this prestigious ranking.
Ludwig Oxford NDM leadership fellow awarded Lee Placito Research Fellowship
Awards and Appointments General Research
8 April 2024
Ludwig Oxford’s Francesco Boccellato has received the prestigious Lee Placito Research Fellowship in Gastrointestinal Cancer
Oxford awarded £9m for the next generation of cancer experts
Awards and Appointments General Research
5 April 2024
Cancer Research UK (CRUK) has awarded £9m to the University of Oxford, to support the next generation of doctors and scientists to bring novel cancer treatments to patients.
Blood tests for diagnosing dementia a step closer
General Research
5 April 2024
The University of Oxford is part of country-wide trials to identify accurate and quick blood tests that can diagnose dementia.
Careful who you believe: University of Oxford leads celebration of hoaxes for April Fools’ Day
General
2 April 2024
April Fakes Day 2024 explores the potential for fakes to reveal hidden truths, as several museums display well known and obscure fakes.
Can we truly align AI with human values? - Q&A with Brian Christian
General
28 March 2024
Brian Christian is an acclaimed American author and researcher who explores the human and societal implications of computer science. His bestselling books include ‘The Most Human Human’ (2011), ‘Algorithms to Live By’ (2016), and ‘The Alignment Problem’ (2021), the latter of which The New York Times said ‘If you’re going to read one book on artificial intelligence, this is the one.’ He holds a degree from Brown University in computer science and philosophy and an MFA in poetry from the University of Washington. Here, Brian talks about the latest chapter of his career journey: starting a DPhil (PhD) at the University of Oxford to grapple with the challenge of designing AI programs that truly align with human values.
Colistin resistant bacteria found in mothers and newborn babies in Nigeria
General Research
28 March 2024
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) and Cardiff University have found evidence that bacteria resistant to colistin, a last-resort antibiotic, were present in mothers and babies under a week old in Nigeria in 2016, despite limited clinical use of colistin at that time in the country. The findings have been published in Nature Communications.
Risk factors for faster aging in the brain revealed in new study
General Research
27 March 2024
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford have used data from UK Biobank participants to reveal that diabetes, traffic-related air pollution and alcohol intake are the most harmful out of 15 modifiable risk factors for dementia
Fire and Wire podcast: Oxford women making a global impact
General
25 March 2024
This International Women's Day (8 March), Professor Irene Tracey sat down with women from across the University who are making a global impact with their work.
New funding for development of world's first lung cancer vaccine
General Research
22 March 2024
Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine.
Celebrating collaboration and resilience: The PRINCIPLE PANORAMIC art exhibition
Clinical Trials Events General
21 March 2024
Celebrate the resilience and collaboration behind Oxford's groundbreaking PANORAMIC and PRINCIPLE COVID-19 trials through "The PANORAMIC PRINCIPLE" exhibition. Artist Tanya Poole's powerful portraits honour the diverse array of participants, researchers, and medical professionals whose inclusive efforts set global benchmarks and transformed lives. An inspiring tribute to human determination in the face of adversity.
Funding to compare imaging modalities for liver cancer detection
General Research
21 March 2024
The DeLIVER early detection of hepatocellular carcinoma research team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.
New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites
General Research
19 March 2024
Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections. The BIO-004 study is being run in partnership between the Department of Biochemistry (Draper Lab, based in the Kavli Institute for Nanoscience Discovery), the University of Edinburgh (Spence Lab, Institute of Immunology and Infection Research) and the Oxford Vaccine Group (part of the Department of Paediatrics). BIO-004 will provide a unique insight into how the immune system adapts over the first few malaria infections of life, learning to tolerate malaria parasites and developing natural immunity to severe illness.
Artificial Intelligence (AI) generated food images look tastier than real ones
General Research
18 March 2024
Researchers have announced an intriguing discovery – consumers generally prefer Artificial Intelligence (AI)-generated images of food over real food images, especially when they are unaware of their true nature. The new findings have been published in Food Quality and Preference.
Oxford wins funding to set up UK’s first registry of those at risk of type 1 diabetes
General Research
15 March 2024
Oxford researchers have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes (T1D), by testing positive for diabetes autoantibodies.